Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Tracking Thinking Recovery After Severe Stroke With a Digital App

Follows thinking recovery in adults after severe middle cerebral artery stroke, using the TuCAN-App.

Plain-language title generated from the registry record
Registry title: Long-Term Cognitive Recovery After Arteria Cerebri Media Ischemia: A Digital Assessment Using the TuCAN-App

Key facts

Where
Tübingen, GermanySee the site

Where in Germany

  • Department of Neurology; University HospitalTübingen, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital Tuebingen
Trial code
NCT07885189
Record updated
21 October 2026
Original description
TuCAN-Media is a longitudinal study investigating cognitive recovery after stroke in severely affected patients (modified Rankin Scale [mRS] score ≥ 3) with large vessel occlusion of the arteria cerebri media/middle cerebral artery (MCA). Cognitive functioning and recovery will be assessed in a comprehensive multi-domain digital-based cognitive testing using the TuCAN-App to facilitate a standardized and rapid testing during the acute phase of a stroke (V2), as well as at 3month(V3)- and 6-month (V4) follow-ups.Read full original descriptionShow less

Digital Cognitive Assessment in Stroke Patients for Evaluating Long-Term Cognitive Recovery: The TuCAN App for Patients With Middle Cerebral Artery Ischemia (TuCAN-Media)"

TuCAN-Media is a longitudinal study investigating cognitive recovery after stroke in severely affected patients (modified Rankin Scale [mRS] score ≥ 3) with large vessel occlusion of the arteria cerebri media/middle cerebral artery (MCA). Cognitive functioning and recovery will be assessed in a comprehensive multi-domain digital-based cognitive testing using the TuCAN-App to facilitate a standardized and rapid testing during the acute phase of a stroke (V2), as well as at 3month(V3)- and 6-month (V4) follow-ups.

Inclusion: ≥ 18 years of age; Right- or left-hemispheric MCA occlusion (MCA segments M1-M3 or corresponding perfusion deficit); modified Rankin Scale (mRS) score ≥ 3 at the time of the index event; Informed consent from the patient or their legal representative.

Exclusion: Pre-existing severe dementia; ≤ 18 years of age; Pregnancy.

ClinicalTrials.gov NCT07885189